News | Peripheral Artery Disease (PAD) | December 29, 2022

Modern Vascular and Local Interventional Radiologist Pair Up To Reduce Unnecessary Amputations in Houston, Texas

Dr. Alexander Shestopalov, MD

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), welcomes a new managing physician, Alexander Shestopalov, MD, Vascular and Interventional Radiologist to its clinic serving the greater Houston area at 7103 South Peek Rd. #300 in Richmond, TX. Modern Vascular will hold a Physician’s Open House Thursday, January 5th 2023 from 4-7pm complete with a meet & greet, tours of the facility and refreshments.

Dr. Shestopalov is a Board-Certified Vascular & Interventional Radiologist, completing his medical degree at the University of Texas Medical Branch in Galveston, TX. He then completed his radiology residency at Albert Einstein College of Medicine in New York and his vascular and interventional radiology training at Baylor Scott & White in Temple, TX. He is now proud to be working at Modern Vascular stating “the team here in Houston is great, I really enjoy working with the team here.   There's a lot of just good vibes here. Everybody gets a lot of support and we're all trying to work toward a common goal, to get out there in the community and try to help as many patients as we possibly can, because PAD is a very rapid condition.” Prior to joining Modern Vascular, Dr. Shestopalov practiced Vascular and Interventional Radiology at the University of Texas Medical Branch starting a program focused on PAD treatment.

PAD affects approximately 8-12 million Americans. Senior citizens or those with a history of diabetes, smoking, obesity, high blood pressure or high cholesterol may be at a higher risk for PAD. In addition, the rate of lower limb amputation due to PAD is high, as is the rate of death following amputation: nearly 50% after one year, 90% within 5 years. According to the Amputee Coalition, in 2014 there were about 4,000 amputations performed in Missouri mostly due to complications from diabetes and peripheral artery disease. This statistic is especially noteworthy as September is PAD Awareness Month.

Modern Vascular’s purpose is focused on saving limbs and lives, returning patients to their homes and families, the same day and in better health. The company’s mission is to eradicate unnecessary lower leg and foot amputation in the general public and specifically among disadvantaged and underserved communities. Over 90% of PAD related amputations are preventable.

Modern Vascular provides an online PAD quiz for patients to determine if they are at risk for PAD. 

For more information: https://modernvascular.com/


Related Content

News | Peripheral Artery Disease (PAD)

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

Home March 08, 2023
Home
News | Peripheral Artery Disease (PAD)

March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were ...

Home March 05, 2023
Home
News | Peripheral Artery Disease (PAD)

November 15, 2022 Performing open bypass surgery to restore circulation for people with a severe form of peripheral ...

Home November 15, 2022
Home
News | Peripheral Artery Disease (PAD)

June 13, 2022 — Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below ...

Home June 13, 2022
Home
News | Peripheral Artery Disease (PAD)

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...

Home May 20, 2022
Home
News | Peripheral Artery Disease (PAD)

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...

Home May 19, 2022
Home
News | Peripheral Artery Disease (PAD)

March 22, 2022 – With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and ...

Home March 22, 2022
Home
News | Peripheral Artery Disease (PAD)
February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School of ...
Home February 21, 2022
Home
News | Peripheral Artery Disease (PAD)
February 15, 2022 – Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a ...
Home February 15, 2022
Home
News | Peripheral Artery Disease (PAD)

January 17, 2022 – The Vascular Care Group (TVCG) announced Stephen J. Hoenig M.D., successfully completed a ...

Home January 17, 2022
Home
Subscribe Now